XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Operating Activities:    
Net income $ 275,961 $ 202,327
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 33,892 31,952
Amortization 10,933 11,463
Gain on sale or disposal of property and equipment (12) (129)
Unrealized foreign currency losses (gains) 2,974 (867)
Deferred income taxes (9,611) (15,713)
Stock compensation expense 30,719 20,732
Realized loss on marketable securities 0 20
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net of allowance for doubtful accounts 108,453 46,873
Inventories 16,545 43,712
Other current and non-current assets 2,117 4,780
Accounts payable (1,281) (4,202)
Other current and non-current liabilities (64,699) (67,405)
Deferred revenue (2,549) (1,876)
Deferred costs (1,451) 622
Income Taxes 33,314 6,921
Net cash provided by operating activities 435,305 279,210
Investing activities:    
Purchases of property and equipment (33,168) (46,814)
Purchase of marketable securities (85,626) (18,684)
Redemption of marketable securities 77,131 57,789
Net cash from (payments for) acquisitions 5,011 0
Other investing activities, net (223) (190)
Net cash used in investing activities (36,875) (7,899)
Financing activities:    
Dividends (140,212) (139,847)
Purchase of treasury stock related to equity awards (15,987) (9,169)
Purchase of treasury stock under share repurchase plan 0 (43,273)
Net cash used in financing activities (156,199) (192,289)
Effect of exchange rate changes on cash and cash equivalents (13,913) 3,387
Net increase in cash, cash equivalents, and restricted cash 228,318 82,409
Cash, cash equivalents, and restricted cash at beginning of period 1,694,156 1,279,912
Cash, cash equivalents, and restricted cash at end of period $ 1,922,474 $ 1,362,321